ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancerInês Mota(Boston Children's Hospital), Roberto Chiarle(Boston Children's Hospital)Nature CancerJuly 10, 202310.1038/s43018-023-00591-2Cited by 41SaveCiteExport RISWatch citationsRelated PapersNPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors|Blood|2003|247Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells|Nature|2017|123Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes|Cancers|2018|97Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma|Blood|2021|48Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1|Oncotarget|2016|45